Share on LinkedInShare on LinkedIn

ARTICLE · 04 SEPTEMBER 2023

D. Mass. Patent Litigation Update, July 2023

Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Contributor
Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Finnegan, Henderson, Farabow, Garrett & Dunner LLP is one of the world’s largest firms focusing on...

View firm profile
Explore more from Finnegan, Henderson, Farabow, Garrett & Dunner LLP

This is part of a series of articles discussing recent orders of interest issued in patent cases by the United States District Court for the District of Massachusetts.

United StatesIntellectual Property

This is part of a series of articles discussing recent orders of interest issued in patent cases by the United States District Court for the District of Massachusetts.

In Enanta Pharmaceuticals, Inc. v. Pfizer, Inc., No. 1:22-cv-10967, Judge Boal resolved five disputes surrounding Enanta's motion to compel Pfizer to apply certain search terms and date ranges in searching its electronically stored information (ESI). searches.

First, Enanta proposed the search term *7321332. Noting that Pfizer used the code name "PF-07321332," the Court found that Enanta's proposed search term was overly broad and ordered Pfizer to run its proposed narrowing term of *7321332 w/5 (SARS* OR COVID*).

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from